HIK — Hikma Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- £3.11bn
- £4.17bn
- $3.35bn
Brief: Hikma CEO Riad Mishlawi Steps Down
UK's Hikma CEO Riad Mishlawi steps down (updated)
Hikma's CEO Riad Mishlawi steps down
Hikma Pharmaceutical - Hikma announces CEO change and Board appointment
Brief: Hikma Launches Tyzavan In The US
UK pharma stocks gain on prospects of UK-US zero-tariff deal
Hikma Pharmaceutical - Holding(s) in Company
Hikma Pharmaceutical - Director/PDMR Shareholding
Hikma Pharmaceutical - Director/PDMR Shareholding
Europe Research Roundup: Azimut, UPM ,Zalando
Live Markets: STOXX dips, Legrand weighs on AI plays, UK banks up
UK's Hikma shares tumble on medium-term profit forecast cut
Brief: Hikma Announces Launch Of Starjemza Injection, Biosimilar Referencing Stelara Injection
UK Stocks-Factors to watch on November 6 (updated)
Hikma lowers medium-term profit forecast on margin pressures (updated)
Brief: Hikma Pharmaceuticals Tightens FY Core Operating Profit Range To $730 Million-$750 Million
Hikma lowers medium-term profit forecast on margin pressures
Hikma Pharmaceutical - November Trading Statement
UK Stocks-Factors to watch on November 6